348 related articles for article (PubMed ID: 20500685)
1. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
[TBL] [Abstract][Full Text] [Related]
2. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
Xu S; Chen J; Wang F; Kang X; Lan T; Wang F; Li Z; Qi Z; Xing J
Transpl Immunol; 2010 Oct; 24(1):57-63. PubMed ID: 20688163
[TBL] [Abstract][Full Text] [Related]
4. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
5. Combination of monoclonal antibodies with DST inhibits accelerated rejection mediated by memory T cells to induce long-lived heart allograft acceptance in mice.
Shao W; Chen J; Dai H; Peng Y; Wang F; Xia J; Thorlacius H; Zhu Q; Qi Z
Immunol Lett; 2011 Aug; 138(2):122-8. PubMed ID: 21477620
[TBL] [Abstract][Full Text] [Related]
6. Suppressing memory T cell activation induces islet allograft tolerance in alloantigen-primed mice.
Xia J; Chen J; Shao W; Lan T; Wang Y; Xie B; Thorlacius H; Tian F; Huang R; Qi Z
Transpl Int; 2010 Nov; 23(11):1154-63. PubMed ID: 20536791
[TBL] [Abstract][Full Text] [Related]
7. CD44/CD70 blockade and anti-CD154/LFA-1 treatment synergistically suppress accelerated rejection and prolong cardiac allograft survival in mice.
Shao W; Yan G; Lin Y; Chen J; Dai H; Wang F; Xi Y; Thorlacius H; Qi Z
Scand J Immunol; 2011 Nov; 74(5):430-7. PubMed ID: 21707692
[TBL] [Abstract][Full Text] [Related]
8. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide is a novel agent for combination therapy to prolong heart allograft survival in allo-primed T cells transferred mice.
Lin Y; Dai H; Su J; Yan G; Xi Y; Ekberg H; Chen J; Qi Z
Transpl Immunol; 2011 Dec; 25(4):194-201. PubMed ID: 21856422
[TBL] [Abstract][Full Text] [Related]
10. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
11. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD44 monoclonal antibody inhibits heart transplant rejection mediated by alloantigen-primed CD4(+) memory T cells in nude mice.
Wang F; Chen J; Shao W; Xie B; Wang Y; Lan T; Thorlacius H; Qi Z
Immunol Invest; 2010; 39(8):807-19. PubMed ID: 20718664
[TBL] [Abstract][Full Text] [Related]
13. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the OX40 ligand prolongs corneal allograft survival.
Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
[TBL] [Abstract][Full Text] [Related]
15. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
16. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
17. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
18. Isatis tinctoria L. combined with co-stimulatory molecules blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
Kang X; Chen J; Qin Q; Wang F; Wang Y; Lan T; Xu S; Wang F; Xia J; Ekberg H; Qi Z; Liu Z
Transpl Immunol; 2010 May; 23(1-2):34-9. PubMed ID: 20338239
[TBL] [Abstract][Full Text] [Related]
19. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
20. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]